233 related articles for article (PubMed ID: 35465813)
1. Yttrium-90 for colorectal liver metastasis - the promising role of radiation segmentectomy as an alternative local cure.
Entezari P; Gabr A; Salem R; Lewandowski RJ
Int J Hyperthermia; 2022; 39(1):620-626. PubMed ID: 35465813
[TBL] [Abstract][Full Text] [Related]
2. Radiation Segmentectomy and Radiation Lobectomy: A Practical Review of Techniques.
Malhotra A; Liu DM; Talenfeld AD
Tech Vasc Interv Radiol; 2019 Jun; 22(2):49-57. PubMed ID: 31079710
[TBL] [Abstract][Full Text] [Related]
3. Transarterial Radioembolization for Management of Hepatocellular Carcinoma.
Badar W; Yu Q; Patel M; Ahmed O
Oncologist; 2024 Feb; 29(2):117-122. PubMed ID: 38128565
[TBL] [Abstract][Full Text] [Related]
4. Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes.
Boas FE; Bodei L; Sofocleous CT
J Nucl Med; 2017 Sep; 58(Suppl 2):104S-111S. PubMed ID: 28864605
[TBL] [Abstract][Full Text] [Related]
5. Evidence-Based Integration of Yttrium-90 Radioembolization in the Contemporary Management of Hepatic Metastases from Colorectal Cancer.
Wang DS; Louie JD; Sze DY
Tech Vasc Interv Radiol; 2019 Jun; 22(2):74-80. PubMed ID: 31079714
[TBL] [Abstract][Full Text] [Related]
6. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
Wang EA; Stein JP; Bellavia RJ; Broadwell SR
Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319
[TBL] [Abstract][Full Text] [Related]
7. Patient Selection and Clinical Outcomes of Y90 in Hepatocellular Carcinoma.
Wehrenberg-Klee E; Gandhi RT; Ganguli S
Tech Vasc Interv Radiol; 2019 Jun; 22(2):70-73. PubMed ID: 31079713
[TBL] [Abstract][Full Text] [Related]
8. Selective internal radiation therapy segmentectomy: A new minimally invasive curative option for primary liver malignancies?
Inchingolo R; Cortese F; Pisani AR; Acquafredda F; Calbi R; Memeo R; Anagnostopoulos F; Spiliopoulos S
World J Gastroenterol; 2024 May; 30(18):2379-2386. PubMed ID: 38764771
[TBL] [Abstract][Full Text] [Related]
9. Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system.
Damm R; Seidensticker R; Ulrich G; Breier L; Steffen IG; Seidensticker M; Garlipp B; Mohnike K; Pech M; Amthauer H; Ricke J
BMC Cancer; 2016 Jul; 16():509. PubMed ID: 27439702
[TBL] [Abstract][Full Text] [Related]
10. Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection.
Vouche M; Lewandowski RJ; Atassi R; Memon K; Gates VL; Ryu RK; Gaba RC; Mulcahy MF; Baker T; Sato K; Hickey R; Ganger D; Riaz A; Fryer J; Caicedo JC; Abecassis M; Kulik L; Salem R
J Hepatol; 2013 Nov; 59(5):1029-36. PubMed ID: 23811303
[TBL] [Abstract][Full Text] [Related]
11. Radioembolization Super Survivors: Extended Survival in Non-operative Hepatocellular Carcinoma.
Gordon AC; Gabr A; Riaz A; Uddin OM; Abouchaleh N; Ali R; Kallini J; Salem R; Lewandowski RJ
Cardiovasc Intervent Radiol; 2018 Oct; 41(10):1557-1565. PubMed ID: 29948005
[TBL] [Abstract][Full Text] [Related]
12. Y90 Radioembolization Dosimetry: Concepts for the Interventional Radiologist.
Toskich BB; Liu DM
Tech Vasc Interv Radiol; 2019 Jun; 22(2):100-111. PubMed ID: 31079706
[TBL] [Abstract][Full Text] [Related]
13. Complete eradication of hepatic metastasis from colorectal cancer by Yttrium-90 SIRT.
Garrean S; Muhs A; Bui JT; Blend MJ; Owens C; Helton WS; Espat NJ
World J Gastroenterol; 2007 Jun; 13(21):3016-9. PubMed ID: 17589957
[TBL] [Abstract][Full Text] [Related]
14. Predictors and prognosticators for survival with Yttrium-90 radioembolization therapy for unresectable colorectal cancer liver metastasis.
Dendy MS; Ludwig JM; Kim HS
Oncotarget; 2017 Jun; 8(23):37912-37922. PubMed ID: 28415671
[TBL] [Abstract][Full Text] [Related]
15. Liver Resection After Selective Internal Radiation Therapy with Yttrium-90 is Safe and Feasible: A Bi-institutional Analysis.
Wright GP; Marsh JW; Varma MK; Doherty MG; Bartlett DL; Chung MH
Ann Surg Oncol; 2017 Apr; 24(4):906-913. PubMed ID: 27878478
[TBL] [Abstract][Full Text] [Related]
16. Update on Embolization Therapies for Hepatocellular Carcinoma.
Kishore S; Friedman T; Madoff DC
Curr Oncol Rep; 2017 Jun; 19(6):40. PubMed ID: 28421483
[TBL] [Abstract][Full Text] [Related]
17. Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization.
Riaz A; Gates VL; Atassi B; Lewandowski RJ; Mulcahy MF; Ryu RK; Sato KT; Baker T; Kulik L; Gupta R; Abecassis M; Benson AB; Omary R; Millender L; Kennedy A; Salem R
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):163-71. PubMed ID: 20421150
[TBL] [Abstract][Full Text] [Related]
18. Radiation Segmentectomy for the Treatment of Primary Hepatic Malignancies of the Caudate Lobe: A Case Series.
Arora M; Toskich BB; Lewis AR; Padula CA; Montazeri SA; Ritchie C; Frey G; Paz-Fumagalli R; McKinney JM; Devcic Z
Cardiovasc Intervent Radiol; 2022 Oct; 45(10):1485-1493. PubMed ID: 36028573
[TBL] [Abstract][Full Text] [Related]
19. Role of Transhepatic Arterial Radioembolization in Metastatic Colorectal Cancer.
Bargellini I; Bozzi E; Lorenzoni G; Boni G; Bianchi F; Traino CA; Masi G; Cioni R; Crocetti L
Cardiovasc Intervent Radiol; 2022 Nov; 45(11):1579-1589. PubMed ID: 36104632
[TBL] [Abstract][Full Text] [Related]
20. Update on Locoregional Therapies for Liver Cancer: Radiation Segmentectomy.
Dadrass F; Sher A; Kim E
Curr Oncol; 2023 Nov; 30(12):10075-10084. PubMed ID: 38132366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]